nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP1A2—Pentoxifylline—systemic scleroderma	0.102	0.32	CbGbCtD
Ropivacaine—CYP1A2—Leflunomide—systemic scleroderma	0.0972	0.305	CbGbCtD
Ropivacaine—CYP2D6—Captopril—systemic scleroderma	0.0628	0.197	CbGbCtD
Ropivacaine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0314	0.0988	CbGbCtD
Ropivacaine—CYP3A4—Prednisone—systemic scleroderma	0.0251	0.079	CbGbCtD
Ropivacaine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00056	0.000821	CcSEcCtD
Ropivacaine—Rash—Mometasone—systemic scleroderma	0.000559	0.000819	CcSEcCtD
Ropivacaine—Asthenia—Captopril—systemic scleroderma	0.000558	0.000819	CcSEcCtD
Ropivacaine—Dermatitis—Mometasone—systemic scleroderma	0.000558	0.000819	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000557	0.000818	CcSEcCtD
Ropivacaine—Osteoarthritis—Methotrexate—systemic scleroderma	0.000556	0.000816	CcSEcCtD
Ropivacaine—Confusional state—Lisinopril—systemic scleroderma	0.000556	0.000815	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000555	0.000815	CcSEcCtD
Ropivacaine—Headache—Mometasone—systemic scleroderma	0.000555	0.000814	CcSEcCtD
Ropivacaine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000554	0.000813	CcSEcCtD
Ropivacaine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000553	0.000812	CcSEcCtD
Ropivacaine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000551	0.000808	CcSEcCtD
Ropivacaine—Pruritus—Captopril—systemic scleroderma	0.00055	0.000808	CcSEcCtD
Ropivacaine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000549	0.000806	CcSEcCtD
Ropivacaine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000549	0.000805	CcSEcCtD
Ropivacaine—Constipation—Leflunomide—systemic scleroderma	0.000548	0.000804	CcSEcCtD
Ropivacaine—Pain—Leflunomide—systemic scleroderma	0.000548	0.000804	CcSEcCtD
Ropivacaine—Infection—Lisinopril—systemic scleroderma	0.000547	0.000803	CcSEcCtD
Ropivacaine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000547	0.000802	CcSEcCtD
Ropivacaine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000545	0.0008	CcSEcCtD
Ropivacaine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000544	0.000798	CcSEcCtD
Ropivacaine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000544	0.000798	CcSEcCtD
Ropivacaine—Shock—Lisinopril—systemic scleroderma	0.000542	0.000795	CcSEcCtD
Ropivacaine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000541	0.000793	CcSEcCtD
Ropivacaine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00054	0.000791	CcSEcCtD
Ropivacaine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000539	0.00079	CcSEcCtD
Ropivacaine—Tachycardia—Lisinopril—systemic scleroderma	0.000538	0.000789	CcSEcCtD
Ropivacaine—Abdominal pain—Azathioprine—systemic scleroderma	0.000537	0.000788	CcSEcCtD
Ropivacaine—Body temperature increased—Azathioprine—systemic scleroderma	0.000537	0.000788	CcSEcCtD
Ropivacaine—Skin disorder—Lisinopril—systemic scleroderma	0.000535	0.000785	CcSEcCtD
Ropivacaine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000533	0.000783	CcSEcCtD
Ropivacaine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000533	0.000781	CcSEcCtD
Ropivacaine—Diarrhoea—Captopril—systemic scleroderma	0.000532	0.000781	CcSEcCtD
Ropivacaine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000531	0.00078	CcSEcCtD
Ropivacaine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000531	0.000778	CcSEcCtD
Ropivacaine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000528	0.000775	CcSEcCtD
Ropivacaine—Mood swings—Methotrexate—systemic scleroderma	0.000527	0.000773	CcSEcCtD
Ropivacaine—Nausea—Mometasone—systemic scleroderma	0.000526	0.000772	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000524	0.000769	CcSEcCtD
Ropivacaine—Pain—Mycophenolic acid—systemic scleroderma	0.000523	0.000767	CcSEcCtD
Ropivacaine—Constipation—Mycophenolic acid—systemic scleroderma	0.000523	0.000767	CcSEcCtD
Ropivacaine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00052	0.000763	CcSEcCtD
Ropivacaine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000519	0.000762	CcSEcCtD
Ropivacaine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000516	0.000757	CcSEcCtD
Ropivacaine—Hypotension—Lisinopril—systemic scleroderma	0.000515	0.000755	CcSEcCtD
Ropivacaine—Dizziness—Captopril—systemic scleroderma	0.000515	0.000755	CcSEcCtD
Ropivacaine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000513	0.000752	CcSEcCtD
Ropivacaine—Depression—Prednisone—systemic scleroderma	0.000512	0.000751	CcSEcCtD
Ropivacaine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000511	0.000749	CcSEcCtD
Ropivacaine—Urticaria—Leflunomide—systemic scleroderma	0.000509	0.000747	CcSEcCtD
Ropivacaine—Abdominal pain—Leflunomide—systemic scleroderma	0.000507	0.000744	CcSEcCtD
Ropivacaine—Body temperature increased—Leflunomide—systemic scleroderma	0.000507	0.000744	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000506	0.000742	CcSEcCtD
Ropivacaine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000504	0.00074	CcSEcCtD
Ropivacaine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000504	0.000739	CcSEcCtD
Ropivacaine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000504	0.000739	CcSEcCtD
Ropivacaine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000504	0.000739	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000503	0.000738	CcSEcCtD
Ropivacaine—Myocardial infarction—Prednisone—systemic scleroderma	0.000503	0.000738	CcSEcCtD
Ropivacaine—Breast disorder—Methotrexate—systemic scleroderma	0.000503	0.000738	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000502	0.000736	CcSEcCtD
Ropivacaine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000502	0.000736	CcSEcCtD
Ropivacaine—Hypersensitivity—Azathioprine—systemic scleroderma	0.0005	0.000734	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.0005	0.000734	CcSEcCtD
Ropivacaine—Insomnia—Lisinopril—systemic scleroderma	0.000498	0.000731	CcSEcCtD
Ropivacaine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000498	0.00073	CcSEcCtD
Ropivacaine—Paraesthesia—Lisinopril—systemic scleroderma	0.000495	0.000726	CcSEcCtD
Ropivacaine—Vomiting—Captopril—systemic scleroderma	0.000495	0.000726	CcSEcCtD
Ropivacaine—Dyspnoea—Lisinopril—systemic scleroderma	0.000491	0.000721	CcSEcCtD
Ropivacaine—Rash—Captopril—systemic scleroderma	0.000491	0.00072	CcSEcCtD
Ropivacaine—Dermatitis—Captopril—systemic scleroderma	0.00049	0.000719	CcSEcCtD
Ropivacaine—Somnolence—Lisinopril—systemic scleroderma	0.00049	0.000719	CcSEcCtD
Ropivacaine—Headache—Captopril—systemic scleroderma	0.000487	0.000715	CcSEcCtD
Ropivacaine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000487	0.000714	CcSEcCtD
Ropivacaine—Dyspepsia—Lisinopril—systemic scleroderma	0.000485	0.000712	CcSEcCtD
Ropivacaine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000484	0.000709	CcSEcCtD
Ropivacaine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000484	0.000709	CcSEcCtD
Ropivacaine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000483	0.000708	CcSEcCtD
Ropivacaine—Infection—Mycophenolate mofetil—systemic scleroderma	0.00048	0.000704	CcSEcCtD
Ropivacaine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000475	0.000697	CcSEcCtD
Ropivacaine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000473	0.000693	CcSEcCtD
Ropivacaine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000472	0.000693	CcSEcCtD
Ropivacaine—Pain—Lisinopril—systemic scleroderma	0.000471	0.000691	CcSEcCtD
Ropivacaine—Constipation—Lisinopril—systemic scleroderma	0.000471	0.000691	CcSEcCtD
Ropivacaine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000471	0.000691	CcSEcCtD
Ropivacaine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000469	0.000688	CcSEcCtD
Ropivacaine—Bradycardia—Prednisone—systemic scleroderma	0.000469	0.000688	CcSEcCtD
Ropivacaine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000467	0.000685	CcSEcCtD
Ropivacaine—Diarrhoea—Azathioprine—systemic scleroderma	0.000465	0.000682	CcSEcCtD
Ropivacaine—Nausea—Captopril—systemic scleroderma	0.000462	0.000678	CcSEcCtD
Ropivacaine—Asthenia—Leflunomide—systemic scleroderma	0.00046	0.000675	CcSEcCtD
Ropivacaine—Hallucination—Prednisone—systemic scleroderma	0.000458	0.000672	CcSEcCtD
Ropivacaine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000454	0.000666	CcSEcCtD
Ropivacaine—Pruritus—Leflunomide—systemic scleroderma	0.000454	0.000666	CcSEcCtD
Ropivacaine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000451	0.000662	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000451	0.000661	CcSEcCtD
Ropivacaine—Dysuria—Methotrexate—systemic scleroderma	0.00045	0.00066	CcSEcCtD
Ropivacaine—Dizziness—Azathioprine—systemic scleroderma	0.000449	0.000659	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00044	0.000645	CcSEcCtD
Ropivacaine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000439	0.000644	CcSEcCtD
Ropivacaine—Diarrhoea—Leflunomide—systemic scleroderma	0.000439	0.000644	CcSEcCtD
Ropivacaine—Urticaria—Lisinopril—systemic scleroderma	0.000438	0.000642	CcSEcCtD
Ropivacaine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000437	0.000641	CcSEcCtD
Ropivacaine—Body temperature increased—Lisinopril—systemic scleroderma	0.000436	0.000639	CcSEcCtD
Ropivacaine—Abdominal pain—Lisinopril—systemic scleroderma	0.000436	0.000639	CcSEcCtD
Ropivacaine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000434	0.000636	CcSEcCtD
Ropivacaine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000433	0.000635	CcSEcCtD
Ropivacaine—Vomiting—Azathioprine—systemic scleroderma	0.000432	0.000633	CcSEcCtD
Ropivacaine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00043	0.000631	CcSEcCtD
Ropivacaine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00063	CcSEcCtD
Ropivacaine—Drowsiness—Methotrexate—systemic scleroderma	0.000429	0.000629	CcSEcCtD
Ropivacaine—Rash—Azathioprine—systemic scleroderma	0.000428	0.000628	CcSEcCtD
Ropivacaine—Dermatitis—Azathioprine—systemic scleroderma	0.000428	0.000628	CcSEcCtD
Ropivacaine—Depression—Methotrexate—systemic scleroderma	0.000428	0.000627	CcSEcCtD
Ropivacaine—Headache—Azathioprine—systemic scleroderma	0.000425	0.000624	CcSEcCtD
Ropivacaine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000425	0.000623	CcSEcCtD
Ropivacaine—Dizziness—Leflunomide—systemic scleroderma	0.000424	0.000622	CcSEcCtD
Ropivacaine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000419	0.000614	CcSEcCtD
Ropivacaine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000413	0.000606	CcSEcCtD
Ropivacaine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000413	0.000606	CcSEcCtD
Ropivacaine—Arrhythmia—Prednisone—systemic scleroderma	0.000412	0.000604	CcSEcCtD
Ropivacaine—Haematuria—Methotrexate—systemic scleroderma	0.000409	0.0006	CcSEcCtD
Ropivacaine—Vomiting—Leflunomide—systemic scleroderma	0.000408	0.000598	CcSEcCtD
Ropivacaine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000406	0.000596	CcSEcCtD
Ropivacaine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000405	0.000593	CcSEcCtD
Ropivacaine—Rash—Leflunomide—systemic scleroderma	0.000404	0.000593	CcSEcCtD
Ropivacaine—Dermatitis—Leflunomide—systemic scleroderma	0.000404	0.000593	CcSEcCtD
Ropivacaine—Mental disorder—Prednisone—systemic scleroderma	0.000404	0.000592	CcSEcCtD
Ropivacaine—Nausea—Azathioprine—systemic scleroderma	0.000403	0.000592	CcSEcCtD
Ropivacaine—Headache—Leflunomide—systemic scleroderma	0.000402	0.000589	CcSEcCtD
Ropivacaine—Erythema—Prednisone—systemic scleroderma	0.000401	0.000588	CcSEcCtD
Ropivacaine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000398	0.000584	CcSEcCtD
Ropivacaine—Asthenia—Lisinopril—systemic scleroderma	0.000395	0.00058	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000395	0.000579	CcSEcCtD
Ropivacaine—Pruritus—Lisinopril—systemic scleroderma	0.00039	0.000572	CcSEcCtD
Ropivacaine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000389	0.000571	CcSEcCtD
Ropivacaine—Rash—Mycophenolic acid—systemic scleroderma	0.000386	0.000566	CcSEcCtD
Ropivacaine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000385	0.000565	CcSEcCtD
Ropivacaine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000384	0.000563	CcSEcCtD
Ropivacaine—Headache—Mycophenolic acid—systemic scleroderma	0.000383	0.000562	CcSEcCtD
Ropivacaine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000382	0.00056	CcSEcCtD
Ropivacaine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000382	0.00056	CcSEcCtD
Ropivacaine—Nausea—Leflunomide—systemic scleroderma	0.000381	0.000559	CcSEcCtD
Ropivacaine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00038	0.000558	CcSEcCtD
Ropivacaine—Vision blurred—Prednisone—systemic scleroderma	0.000378	0.000554	CcSEcCtD
Ropivacaine—Urethral disorder—Methotrexate—systemic scleroderma	0.000377	0.000554	CcSEcCtD
Ropivacaine—Diarrhoea—Lisinopril—systemic scleroderma	0.000377	0.000553	CcSEcCtD
Ropivacaine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000372	0.000546	CcSEcCtD
Ropivacaine—Anaemia—Prednisone—systemic scleroderma	0.000371	0.000544	CcSEcCtD
Ropivacaine—Agitation—Prednisone—systemic scleroderma	0.000368	0.000541	CcSEcCtD
Ropivacaine—Angioedema—Prednisone—systemic scleroderma	0.000366	0.000538	CcSEcCtD
Ropivacaine—Dizziness—Lisinopril—systemic scleroderma	0.000364	0.000535	CcSEcCtD
Ropivacaine—Nausea—Mycophenolic acid—systemic scleroderma	0.000363	0.000533	CcSEcCtD
Ropivacaine—Malaise—Prednisone—systemic scleroderma	0.000362	0.00053	CcSEcCtD
Ropivacaine—Vertigo—Prednisone—systemic scleroderma	0.00036	0.000529	CcSEcCtD
Ropivacaine—Syncope—Prednisone—systemic scleroderma	0.00036	0.000528	CcSEcCtD
Ropivacaine—Tinnitus—Methotrexate—systemic scleroderma	0.000359	0.000527	CcSEcCtD
Ropivacaine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000357	0.000524	CcSEcCtD
Ropivacaine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000356	0.000522	CcSEcCtD
Ropivacaine—Loss of consciousness—Prednisone—systemic scleroderma	0.000352	0.000517	CcSEcCtD
Ropivacaine—Vomiting—Lisinopril—systemic scleroderma	0.00035	0.000514	CcSEcCtD
Ropivacaine—Rash—Lisinopril—systemic scleroderma	0.000347	0.00051	CcSEcCtD
Ropivacaine—Convulsion—Prednisone—systemic scleroderma	0.000347	0.00051	CcSEcCtD
Ropivacaine—Dermatitis—Lisinopril—systemic scleroderma	0.000347	0.000509	CcSEcCtD
Ropivacaine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000346	0.000508	CcSEcCtD
Ropivacaine—Hypertension—Prednisone—systemic scleroderma	0.000346	0.000508	CcSEcCtD
Ropivacaine—Chills—Methotrexate—systemic scleroderma	0.000345	0.000507	CcSEcCtD
Ropivacaine—Headache—Lisinopril—systemic scleroderma	0.000345	0.000506	CcSEcCtD
Ropivacaine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000342	0.000501	CcSEcCtD
Ropivacaine—Arthralgia—Prednisone—systemic scleroderma	0.000341	0.000501	CcSEcCtD
Ropivacaine—Myalgia—Prednisone—systemic scleroderma	0.000341	0.000501	CcSEcCtD
Ropivacaine—Anxiety—Prednisone—systemic scleroderma	0.00034	0.000499	CcSEcCtD
Ropivacaine—Discomfort—Prednisone—systemic scleroderma	0.000337	0.000495	CcSEcCtD
Ropivacaine—Mental disorder—Methotrexate—systemic scleroderma	0.000337	0.000495	CcSEcCtD
Ropivacaine—Erythema—Methotrexate—systemic scleroderma	0.000335	0.000492	CcSEcCtD
Ropivacaine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00033	0.000485	CcSEcCtD
Ropivacaine—Nausea—Lisinopril—systemic scleroderma	0.000327	0.00048	CcSEcCtD
Ropivacaine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000327	0.00048	CcSEcCtD
Ropivacaine—Infection—Prednisone—systemic scleroderma	0.000325	0.000477	CcSEcCtD
Ropivacaine—Back pain—Methotrexate—systemic scleroderma	0.000324	0.000476	CcSEcCtD
Ropivacaine—Shock—Prednisone—systemic scleroderma	0.000322	0.000472	CcSEcCtD
Ropivacaine—Tachycardia—Prednisone—systemic scleroderma	0.000319	0.000469	CcSEcCtD
Ropivacaine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000319	0.000468	CcSEcCtD
Ropivacaine—Skin disorder—Prednisone—systemic scleroderma	0.000318	0.000466	CcSEcCtD
Ropivacaine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000316	0.000464	CcSEcCtD
Ropivacaine—Vision blurred—Methotrexate—systemic scleroderma	0.000316	0.000463	CcSEcCtD
Ropivacaine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000311	0.000456	CcSEcCtD
Ropivacaine—Anaemia—Methotrexate—systemic scleroderma	0.00031	0.000454	CcSEcCtD
Ropivacaine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000307	0.00045	CcSEcCtD
Ropivacaine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000304	0.000447	CcSEcCtD
Ropivacaine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000304	0.000446	CcSEcCtD
Ropivacaine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000302	0.000444	CcSEcCtD
Ropivacaine—Malaise—Methotrexate—systemic scleroderma	0.000302	0.000443	CcSEcCtD
Ropivacaine—Vertigo—Methotrexate—systemic scleroderma	0.000301	0.000442	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000298	0.000437	CcSEcCtD
Ropivacaine—Insomnia—Prednisone—systemic scleroderma	0.000296	0.000434	CcSEcCtD
Ropivacaine—Paraesthesia—Prednisone—systemic scleroderma	0.000294	0.000431	CcSEcCtD
Ropivacaine—Cough—Methotrexate—systemic scleroderma	0.000292	0.000429	CcSEcCtD
Ropivacaine—Convulsion—Methotrexate—systemic scleroderma	0.00029	0.000426	CcSEcCtD
Ropivacaine—Dyspepsia—Prednisone—systemic scleroderma	0.000288	0.000423	CcSEcCtD
Ropivacaine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000287	0.000421	CcSEcCtD
Ropivacaine—Arthralgia—Methotrexate—systemic scleroderma	0.000285	0.000419	CcSEcCtD
Ropivacaine—Chest pain—Methotrexate—systemic scleroderma	0.000285	0.000419	CcSEcCtD
Ropivacaine—Myalgia—Methotrexate—systemic scleroderma	0.000285	0.000419	CcSEcCtD
Ropivacaine—Discomfort—Methotrexate—systemic scleroderma	0.000282	0.000414	CcSEcCtD
Ropivacaine—Constipation—Prednisone—systemic scleroderma	0.00028	0.000411	CcSEcCtD
Ropivacaine—Confusional state—Methotrexate—systemic scleroderma	0.000276	0.000405	CcSEcCtD
Ropivacaine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000274	0.000401	CcSEcCtD
Ropivacaine—Infection—Methotrexate—systemic scleroderma	0.000272	0.000399	CcSEcCtD
Ropivacaine—Feeling abnormal—Prednisone—systemic scleroderma	0.00027	0.000396	CcSEcCtD
Ropivacaine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000268	0.000393	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000268	0.000393	CcSEcCtD
Ropivacaine—Skin disorder—Methotrexate—systemic scleroderma	0.000266	0.00039	CcSEcCtD
Ropivacaine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000264	0.000388	CcSEcCtD
Ropivacaine—Urticaria—Prednisone—systemic scleroderma	0.00026	0.000381	CcSEcCtD
Ropivacaine—Body temperature increased—Prednisone—systemic scleroderma	0.000259	0.00038	CcSEcCtD
Ropivacaine—Abdominal pain—Prednisone—systemic scleroderma	0.000259	0.00038	CcSEcCtD
Ropivacaine—Hypotension—Methotrexate—systemic scleroderma	0.000256	0.000375	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000249	0.000366	CcSEcCtD
Ropivacaine—Insomnia—Methotrexate—systemic scleroderma	0.000247	0.000363	CcSEcCtD
Ropivacaine—Paraesthesia—Methotrexate—systemic scleroderma	0.000246	0.00036	CcSEcCtD
Ropivacaine—Dyspnoea—Methotrexate—systemic scleroderma	0.000244	0.000358	CcSEcCtD
Ropivacaine—Somnolence—Methotrexate—systemic scleroderma	0.000243	0.000357	CcSEcCtD
Ropivacaine—Hypersensitivity—Prednisone—systemic scleroderma	0.000241	0.000354	CcSEcCtD
Ropivacaine—Dyspepsia—Methotrexate—systemic scleroderma	0.000241	0.000353	CcSEcCtD
Ropivacaine—Asthenia—Prednisone—systemic scleroderma	0.000235	0.000344	CcSEcCtD
Ropivacaine—Pain—Methotrexate—systemic scleroderma	0.000234	0.000343	CcSEcCtD
Ropivacaine—Pruritus—Prednisone—systemic scleroderma	0.000232	0.00034	CcSEcCtD
Ropivacaine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000225	0.000331	CcSEcCtD
Ropivacaine—Diarrhoea—Prednisone—systemic scleroderma	0.000224	0.000328	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000224	0.000328	CcSEcCtD
Ropivacaine—Urticaria—Methotrexate—systemic scleroderma	0.000217	0.000319	CcSEcCtD
Ropivacaine—Dizziness—Prednisone—systemic scleroderma	0.000216	0.000317	CcSEcCtD
Ropivacaine—Abdominal pain—Methotrexate—systemic scleroderma	0.000216	0.000317	CcSEcCtD
Ropivacaine—Body temperature increased—Methotrexate—systemic scleroderma	0.000216	0.000317	CcSEcCtD
Ropivacaine—Vomiting—Prednisone—systemic scleroderma	0.000208	0.000305	CcSEcCtD
Ropivacaine—Rash—Prednisone—systemic scleroderma	0.000206	0.000303	CcSEcCtD
Ropivacaine—Dermatitis—Prednisone—systemic scleroderma	0.000206	0.000302	CcSEcCtD
Ropivacaine—Headache—Prednisone—systemic scleroderma	0.000205	0.000301	CcSEcCtD
Ropivacaine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000202	0.000296	CcSEcCtD
Ropivacaine—Asthenia—Methotrexate—systemic scleroderma	0.000196	0.000288	CcSEcCtD
Ropivacaine—Nausea—Prednisone—systemic scleroderma	0.000194	0.000285	CcSEcCtD
Ropivacaine—Pruritus—Methotrexate—systemic scleroderma	0.000194	0.000284	CcSEcCtD
Ropivacaine—Diarrhoea—Methotrexate—systemic scleroderma	0.000187	0.000275	CcSEcCtD
Ropivacaine—Dizziness—Methotrexate—systemic scleroderma	0.000181	0.000265	CcSEcCtD
Ropivacaine—Vomiting—Methotrexate—systemic scleroderma	0.000174	0.000255	CcSEcCtD
Ropivacaine—Rash—Methotrexate—systemic scleroderma	0.000172	0.000253	CcSEcCtD
Ropivacaine—Dermatitis—Methotrexate—systemic scleroderma	0.000172	0.000253	CcSEcCtD
Ropivacaine—Headache—Methotrexate—systemic scleroderma	0.000171	0.000251	CcSEcCtD
Ropivacaine—Nausea—Methotrexate—systemic scleroderma	0.000162	0.000238	CcSEcCtD
